Search Results - "Hasle, H"

A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases by HASLE, H, NIEMEYER, C. M, CHESSELLS, J. M, BAUMANN, I, BENNETT, J. M, KERNDRUP, G, HEAD, D. R

“…Myelodysplastic and myeloproliferative disorders are rare in childhood and there is no widely accepted system for their diagnosis and classification. We…”
Get full text

Engaging carers in neuropsychological rehabilitation for brain cancer survivors: The “I’m aware: Patients And Carers Together” (ImPACT) program by Buskbjerg, C.R., Amidi, A., Munk, A., Danielsen, J.T., Henriksen, L.T., Lukacova, S., Haldbo-Classen, L., Evald, J., Evald, L., Lassen-Ramshad, Y., Zachariae, R., Høyer, M., Hasle, H., Wu, L.M.

“…Cognitive impairment is a common late effect in child and adult brain cancer survivors (BCS). Still, there is a dearth of research aimed at therapeutic…”
Get full text

The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01 by Creutzig, Ursula, Zimmermann, Martin, Dworzak, Michael N, Gibson, Brenda, Tamminga, Rienk, Abrahamsson, Jonas, Ha, Shau-Yin, Hasle, Henrik, Maschan, Alexey, Bertrand, Yves, Leverger, Guy, von Neuhoff, Christine, Razzouk, Bassem, Rizzari, Carmelo, Smisek, Petr, Smith, Owen P, Stark, Batia, Reinhardt, Dirk, Kaspers, Gertjan L

“…The prognostic significance of early response to treatment has not been reported in relapsed pediatric acute myeloid leukemia. In order to identify an early…”
Get full text

Long-term results in children with AML: NOPHO-AML Study Group - report of three consecutive trials by Lie, S O, Abrahamsson, J, Clausen, N, Forestier, E, Hasle, H, Hovi, L, Jonmundsson, G, Mellander, L, Siimes, M A, Yssing, M, Zeller, B, Gustafsson, G

“…In all, 447 children with acute myeloid leukaemia (AML) have been treated on three consecutive NOPHO studies from July 1984 to December 2001. NOPHO-AML 84 was…”
Get full text

Osteoporotic Fractures in Childhood Cancer Survivors - ALICCS Cohort Study by Oskarsson, T., Duun-Henriksen, A. K., Harila-Saari, A., Montgomery, Scott, Niinimaki, R., Madanat-Harjuoja, L., Tryggvadottir, L., Wesenberg, F., Holmqvist, A. S., Hasle, H., Heyman, M., Winther, J. F.

“…Background/Objectives : Children and adolescents undergoing treatment for cancer are exposed to multiple factors that impact the development of peak bone mass…”
Get full text

Incidence of essential thrombocythaemia in children by Hasle, Henrik

Get full text

Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study by Blink, M., Zimmermann, M., von Neuhoff, C., Reinhardt, D., de Haas, V., Hasle, H., O'Brien, M. M., Stark, B., Tandonnet, J., Pession, A., Tousovska, K., Cheuk, D. K. L., Kudo, K., Taga, T., Rubnitz, J. E., Haltrich, I., Balwierz, W., Pieters, R., Forestier, E., Johansson, B., van den Heuvel-Eibrink, M. M., Zwaan, C. M.

“…Myeloid leukemia of Down syndrome has a better prognosis than sporadic pediatric acute myeloid leukemia. Most cases of myeloid leukemia of Down syndrome are…”
Get full text

Whole-genome-amplified DNA as a source for mutational analysis underestimates the frequency of mutations in pediatric acute myeloid leukemia by Rosenquist, R, Ehrencrona, H, Hasle, H, Palle, J, Kanduri, M

Get full text

The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML) by HASLE, H, BAUMANN, I, STARY, J, TREBO, M, VAN DEN HEUVEL-EIBRINK, M. M, HARBOTT, J, NÖLLKE, P, NIEMEYER, C. M, BERGSTRÄSSER, E, FENU, S, FISCHER, A, KARDOS, G, KERNDRUP, G, LOCATELLI, F, ROGGE, T, SCHULTZ, K. R

“…The International Prognostic Scoring System (IPSS) for myelodysplastic syndrome (MDS) is based upon weighted data on bone marrow (BM) blast percentage,…”
Get full text

The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS by Aalbers, A M, van der Velden, V H J, Yoshimi, A, Fischer, A, Noellke, P, Zwaan, C M, Baumann, I, Beverloo, H B, Dworzak, M, Hasle, H, Locatelli, F, De Moerloose, B, Göhring, G, Schmugge, M, Stary, J, Zecca, M, Langerak, A W, van Dongen, J J M, Pieters, R, Niemeyer, C M, van den Heuvel-Eibrink, M M

Get full text

Complex three-way translocation involving MLL, ELL, RREB1, and CMAHP genes in an infant with acute myeloid leukemia and t(6;19;11)(p22.2;p13.1;q23.3) by Tuborgh, A, Meyer, C, Marschalek, R, Preiss, B, Hasle, H, Kjeldsen, E

“…Rearrangements affecting the MLL gene in hematological malignancies are associated with poor prognosis. Most often they are reciprocal translocations and more…”
Get more information

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML by Hasle, H, Abrahamsson, J, Arola, M, Karow, A, O'Marcaigh, A, Reinhardt, D, Webb, D K H, van Wering, E, Zeller, B, Zwaan, C M, Vyas, P

Get full text

Children with low‐risk acute lymphoblastic leukemia are at highest risk of second cancers by Nielsen, Stine N., Eriksson, Frank, Rosthoej, Susanne, Andersen, Mette K., Forestier, Erik, Hasle, Henrik, Hjalgrim, Lisa L., Aasberg, Ann, Abrahamsson, Jonas, Heyman, Mats, Jónsson, Ólafur G., Pruunsild, Kaie, Vaitkeviciené, Goda E., Vettenranta, Kim, Schmiegelow, Kjeld

“…Background The improved survival rates for childhood acute lymphoblastic leukemia (ALL) may be jeopardized by the development of a second cancer, which has…”
Get full text

PB1938: 4WHIM: EVALUATING MAVORIXAFOR, AN ORAL CXCR4 ANTAGONIST, IN PATIENTS WITH WHIM SYNDROME VIA A GLOBAL PHASE 3, RANDOMIZED, PLACEBO‐CONTROLLED TRIAL WITH OPEN‐LABEL EXTENSION by Dale, D. C., Alsina, L., Azar, A., Badolato, R., Bertrand, Y., Deya, A., Dickerson, K. E., Ezra, N., Hasle, H., Kang, H. J., Kiani‐Alikhan, S., Kuijpers, T., Kulagin, A., Langguth, D., Levin, C., Neth, O., Peake, J., Rutten, C. E., Shcherbina, A., Tarrant, T. K., Vossen, M. G., Wysocki, C. A., Belschner, A., Cadavid, D., Hu, Y., Jiang, H., MacLeod, R., Tang, W., Tillinger, M., Donadieu, J.

Get full text

Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemia by Blink, M, Buitenkamp, T D, van den Heuvel-Eibrink, M M, Danen-van Oorschot, A A, de Haas, V, Reinhardt, D, Klusmann, J-H, Zimmermann, M, Devidas, M, Carroll, A J, Basso, G, Pession, A, Hasle, H, Pieters, R, Rabin, K R, Izraeli, S, Zwaan, C M

Get full text

Acute leukaemia in children with Down syndrome: a population‐based Nordic study by Zeller, Bernward, Gustafsson, Göran, Forestier, Erik, Abrahamsson, Jonas, Clausen, Niels, Heldrup, Jesper, Hovi, Liisa, Jonmundsson, Gudmundur, Lie, Sverre O., Glomstein, Anders, Hasle, Henrik

“…Summary To determine the epidemiology and outcome of children with Down syndrome (DS) diagnosed with acute leukaemia in the Nordic countries, data registered…”
Get full text

Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood by Aalbers, A M, van den Heuvel-Eibrink, M M, de Haas, V, te Marvelde, J G, de Jong, A X, van der Burg, M, Dworzak, M, Hasle, H, Locatelli, F, De Moerloose, B, Schmugge, M, Stary, J, Zecca, M, Zwaan, C M, van de Loosdrecht, A A, van Dongen, J J M, Niemeyer, C M, van der Velden, V H J

“…3 0 0 0 0 0 of 3 (0)…”
Get full text

293 FAMILIAL MYELODYSPLASTIC SYNDROME (MDS) IN TWO DANISH FAMILIES - TWO NEW PREDISPOSING TERC MUTATIONS IDENTIFIED by Raaschou-lensen, K, Norberg, A, Andersen, M. Klarskov, Jönson, L, Kjeldsen, E, Grønbæk, K, Nederby, L, Holm, M. Skov, Hasle, H, Nielsen, F. Cilius, Roos, G, Kjeldsen, L

Get full text

Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: Biological and clinical implications by Nyvold, C G, Stentoft, J, Braendstrup, K, Melsvik, D, Moestrup, S K, Juhl-Christensen, C, Hasle, H, Hokland, P

Get full text

Cancer incidence in men with Klinefelter syndrome by HASLE, H, MELLEMGAARD, A, NIELSEN, J, HANSEN, J

“…Many case reports have suggested an association between Klinefelter syndrome (KS) and cancer, but studies of the cancer incidence in larger groups of men with…”
Get full text